APO Research

APO RESEARCH · REPORT

Vendor Neutral Archive (VNA) & PACS

Selected research

Industry Growth & Trends

Global Vendor Neutral Archive (VNA) & PACS Industry Growth and Trends Forecast to 2032

Market perspective

According to APO Research, the global Vendor Neutral Archive (VNA) & PACS market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Vendor Neutral Archive (VNA) & PACS is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Vendor Neutral Archive (VNA) & PACS is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Vendor Neutral Archive (VNA) & PACS is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Vendor Neutral Archive (VNA) & PACS market include GE Healthcare Technologies Inc., Siemens Healthcare Limited, Canon Medical Systems Corporation, FUJIFILM Holdings Corporation, Agfa-Gevaert Group, Sectra AB, Hyland Software, Inc., Intelerad Medical Systems Inc and Merative, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Vendor Neutral Archive (VNA) & PACS market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Vendor Neutral Archive (VNA) & PACS market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Vendor Neutral Archive (VNA) & PACS market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Vendor Neutral Archive (VNA) & PACS.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Vendor Neutral Archive (VNA) & PACS market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Vendor Neutral Archive (VNA) & PACS Market by Company

GE Healthcare Technologies Inc.

Siemens Healthcare Limited

Canon Medical Systems Corporation

FUJIFILM Holdings Corporation

Agfa-Gevaert Group

Sectra AB

Hyland Software, Inc.

Intelerad Medical Systems Inc

Merative

Novarad Corporation

Esaote SPA

Dedalus s.p.A.

BridgeHead Software Ltd.

PaxeraHealth

Medicasoft

Visus Health IT GmbH

POSTDICOM

Vendor Neutral Archive (VNA) & PACS Segment by Type

CT

MRl

X-rays

Ultrasound

Mammo

PET

Vendor Neutral Archive (VNA) & PACS Segment by Application

Hospital

Surgery Center

Other

Vendor Neutral Archive (VNA) & PACS Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vendor Neutral Archive (VNA) & PACS market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vendor Neutral Archive (VNA) & PACS and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vendor Neutral Archive (VNA) & PACS.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Vendor Neutral Archive (VNA) & PACS companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Vendor Neutral Archive (VNA) & PACS Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Vendor Neutral Archive (VNA) & PACS Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Vendor Neutral Archive (VNA) & PACS Market Share by Region (2021-2026) Table 4. Global Vendor Neutral Archive (VNA) & PACS Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Vendor Neutral Archive (VNA) & PACS Market Share by Region (2027-2032) Table 6. Global Vendor Neutral Archive (VNA) & PACS Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Vendor Neutral Archive (VNA) & PACS Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Vendor Neutral Archive (VNA) & PACS Market Size Share by Type (2021-2026) Table 9. Global Vendor Neutral Archive (VNA) & PACS Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Vendor Neutral Archive (VNA) & PACS Market Size Share Forecasted by Type (2027-2032) Table 11. North America Vendor Neutral Archive (VNA) & PACS Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Vendor Neutral Archive (VNA) & PACS Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Vendor Neutral Archive (VNA) & PACS Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Vendor Neutral Archive (VNA) & PACS Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Vendor Neutral Archive (VNA) & PACS Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Vendor Neutral Archive (VNA) & PACS Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Vendor Neutral Archive (VNA) & PACS Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Vendor Neutral Archive (VNA) & PACS Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Vendor Neutral Archive (VNA) & PACS Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Vendor Neutral Archive (VNA) & PACS Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Vendor Neutral Archive (VNA) & PACS Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Vendor Neutral Archive (VNA) & PACS Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Vendor Neutral Archive (VNA) & PACS Market Size Share by Application (2021-2026) Table 24. Global Vendor Neutral Archive (VNA) & PACS Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Vendor Neutral Archive (VNA) & PACS Market Size Share Forecasted by Application (2027-2032) Table 26. North America Vendor Neutral Archive (VNA) & PACS Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Vendor Neutral Archive (VNA) & PACS Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Vendor Neutral Archive (VNA) & PACS Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Vendor Neutral Archive (VNA) & PACS Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Vendor Neutral Archive (VNA) & PACS Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Vendor Neutral Archive (VNA) & PACS Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Vendor Neutral Archive (VNA) & PACS Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Vendor Neutral Archive (VNA) & PACS Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Vendor Neutral Archive (VNA) & PACS Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Vendor Neutral Archive (VNA) & PACS Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Vendor Neutral Archive (VNA) & PACS Industry Trends Table 37. Vendor Neutral Archive (VNA) & PACS Industry Drivers Table 38. Vendor Neutral Archive (VNA) & PACS Industry Opportunities and Challenges Table 39. Vendor Neutral Archive (VNA) & PACS Industry Restraints Table 40. Global Vendor Neutral Archive (VNA) & PACS Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Vendor Neutral Archive (VNA) & PACS Revenue Market Share by Company (2021-2026) Table 42. Global Vendor Neutral Archive (VNA) & PACS Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Vendor Neutral Archive (VNA) & PACS Key Company Headquarters & Area Served Table 44. Global Vendor Neutral Archive (VNA) & PACS Company, Product Type & Application Table 45. Global Vendor Neutral Archive (VNA) & PACS Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Vendor Neutral Archive (VNA) & PACS by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. GE Healthcare Technologies Inc. Company Information Table 49. GE Healthcare Technologies Inc. Business Overview Table 50. GE Healthcare Technologies Inc. Vendor Neutral Archive (VNA) & PACS Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. GE Healthcare Technologies Inc. Vendor Neutral Archive (VNA) & PACS Product Portfolio Table 52. GE Healthcare Technologies Inc. Recent Development Table 53. Siemens Healthcare Limited Company Information Table 54. Siemens Healthcare Limited Business Overview Table 55. Siemens Healthcare Limited Vendor Neutral Archive (VNA) & PACS Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Siemens Healthcare Limited Vendor Neutral Archive (VNA) & PACS Product Portfolio Table 57. Siemens Healthcare Limited Recent Development Table 58. Canon Medical Systems Corporation Company Information Table 59. Canon Medical Systems Corporation Business Overview Table 60. Canon Medical Systems Corporation Vendor Neutral Archive (VNA) & PACS Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Canon Medical Systems Corporation Vendor Neutral Archive (VNA) & PACS Product Portfolio Table 62. Canon Medical Systems Corporation Recent Development Table 63. FUJIFILM Holdings Corporation Company Information Table 64. FUJIFILM Holdings Corporation Business Overview Table 65. FUJIFILM Holdings Corporation Vendor Neutral Archive (VNA) & PACS Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. FUJIFILM Holdings Corporation Vendor Neutral Archive (VNA) & PACS Product Portfolio Table 67. FUJIFILM Holdings Corporation Recent Development Table 68. Agfa-Gevaert Group Company Information Table 69. Agfa-Gevaert Group Business Overview Table 70. Agfa-Gevaert Group Vendor Neutral Archive (VNA) & PACS Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Agfa-Gevaert Group Vendor Neutral Archive (VNA) & PACS Product Portfolio Table 72. Agfa-Gevaert Group Recent Development Table 73. Sectra AB Company Information Table 74. Sectra AB Business Overview Table 75. Sectra AB Vendor Neutral Archive (VNA) & PACS Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Sectra AB Vendor Neutral Archive (VNA) & PACS Product Portfolio Table 77. Sectra AB Recent Development Table 78. Hyland Software, Inc. Company Information Table 79. Hyland Software, Inc. Business Overview Table 80. Hyland Software, Inc. Vendor Neutral Archive (VNA) & PACS Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Hyland Software, Inc. Vendor Neutral Archive (VNA) & PACS Product Portfolio Table 82. Hyland Software, Inc. Recent Development Table 83. Intelerad Medical Systems Inc Company Information Table 84. Intelerad Medical Systems Inc Business Overview Table 85. Intelerad Medical Systems Inc Vendor Neutral Archive (VNA) & PACS Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Intelerad Medical Systems Inc Vendor Neutral Archive (VNA) & PACS Product Portfolio Table 87. Intelerad Medical Systems Inc Recent Development Table 88. Merative Company Information Table 89. Merative Business Overview Table 90. Merative Vendor Neutral Archive (VNA) & PACS Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Merative Vendor Neutral Archive (VNA) & PACS Product Portfolio Table 92. Merative Recent Development Table 93. Novarad Corporation Company Information Table 94. Novarad Corporation Business Overview Table 95. Novarad Corporation Vendor Neutral Archive (VNA) & PACS Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Novarad Corporation Vendor Neutral Archive (VNA) & PACS Product Portfolio Table 97. Novarad Corporation Recent Development Table 98. Esaote SPA Company Information Table 99. Esaote SPA Business Overview Table 100. Esaote SPA Vendor Neutral Archive (VNA) & PACS Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Esaote SPA Vendor Neutral Archive (VNA) & PACS Product Portfolio Table 102. Esaote SPA Recent Development Table 103. Dedalus s.p.A. Company Information Table 104. Dedalus s.p.A. Business Overview Table 105. Dedalus s.p.A. Vendor Neutral Archive (VNA) & PACS Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Dedalus s.p.A. Vendor Neutral Archive (VNA) & PACS Product Portfolio Table 107. Dedalus s.p.A. Recent Development Table 108. BridgeHead Software Ltd. Company Information Table 109. BridgeHead Software Ltd. Business Overview Table 110. BridgeHead Software Ltd. Vendor Neutral Archive (VNA) & PACS Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. BridgeHead Software Ltd. Vendor Neutral Archive (VNA) & PACS Product Portfolio Table 112. BridgeHead Software Ltd. Recent Development Table 113. PaxeraHealth Company Information Table 114. PaxeraHealth Business Overview Table 115. PaxeraHealth Vendor Neutral Archive (VNA) & PACS Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. PaxeraHealth Vendor Neutral Archive (VNA) & PACS Product Portfolio Table 117. PaxeraHealth Recent Development Table 118. Medicasoft Company Information Table 119. Medicasoft Business Overview Table 120. Medicasoft Vendor Neutral Archive (VNA) & PACS Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Medicasoft Vendor Neutral Archive (VNA) & PACS Product Portfolio Table 122. Medicasoft Recent Development Table 123. Visus Health IT GmbH Company Information Table 124. Visus Health IT GmbH Business Overview Table 125. Visus Health IT GmbH Vendor Neutral Archive (VNA) & PACS Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Visus Health IT GmbH Vendor Neutral Archive (VNA) & PACS Product Portfolio Table 127. Visus Health IT GmbH Recent Development Table 128. POSTDICOM Company Information Table 129. POSTDICOM Business Overview Table 130. POSTDICOM Vendor Neutral Archive (VNA) & PACS Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. POSTDICOM Vendor Neutral Archive (VNA) & PACS Product Portfolio Table 132. POSTDICOM Recent Development Table 133. North America Vendor Neutral Archive (VNA) & PACS Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. North America Vendor Neutral Archive (VNA) & PACS Market Size by Country (2021-2026) & (US$ Million) Table 135. North America Vendor Neutral Archive (VNA) & PACS Market Share by Country (2021-2026) Table 136. North America Vendor Neutral Archive (VNA) & PACS Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. North America Vendor Neutral Archive (VNA) & PACS Market Share Forecast by Country (2027-2032) Table 138. Europe Vendor Neutral Archive (VNA) & PACS Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Europe Vendor Neutral Archive (VNA) & PACS Market Size by Country (2021-2026) & (US$ Million) Table 140. Europe Vendor Neutral Archive (VNA) & PACS Market Share by Country (2021-2026) Table 141. Europe Vendor Neutral Archive (VNA) & PACS Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Europe Vendor Neutral Archive (VNA) & PACS Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Vendor Neutral Archive (VNA) & PACS Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Vendor Neutral Archive (VNA) & PACS Market Size by Country (2021-2026) & (US$ Million) Table 145. Asia-Pacific Vendor Neutral Archive (VNA) & PACS Market Share by Country (2021-2026) Table 146. Asia-Pacific Vendor Neutral Archive (VNA) & PACS Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Asia-Pacific Vendor Neutral Archive (VNA) & PACS Market Share Forecast by Country (2027-2032) Table 148. Latin America Vendor Neutral Archive (VNA) & PACS Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Latin America Vendor Neutral Archive (VNA) & PACS Market Size by Country (2021-2026) & (US$ Million) Table 150. Latin America Vendor Neutral Archive (VNA) & PACS Market Share by Country (2021-2026) Table 151. Latin America Vendor Neutral Archive (VNA) & PACS Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Latin America Vendor Neutral Archive (VNA) & PACS Market Share Forecast by Country (2027-2032) Table 153. Middle East & Africa Vendor Neutral Archive (VNA) & PACS Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Middle East & Africa Vendor Neutral Archive (VNA) & PACS Market Size by Country (2021-2026) & (US$ Million) Table 155. Middle East & Africa Vendor Neutral Archive (VNA) & PACS Market Share by Country (2021-2026) Table 156. Middle East & Africa Vendor Neutral Archive (VNA) & PACS Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Middle East & Africa Vendor Neutral Archive (VNA) & PACS Market Share Forecast by Country (2027-2032) Table 158. Research Programs/Design for This Report Table 159. Authors List of This Report Table 160. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Vendor Neutral Archive (VNA) & PACS Product Image Figure 3. Global Vendor Neutral Archive (VNA) & PACS Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Vendor Neutral Archive (VNA) & PACS Market Size (2021-2032) & (US$ Million) Figure 5. Global Vendor Neutral Archive (VNA) & PACS Market Share by Region: 2025 VS 2032 Figure 6. Global Vendor Neutral Archive (VNA) & PACS Market Share by Region (2021-2032) Figure 7. North America Vendor Neutral Archive (VNA) & PACS Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Vendor Neutral Archive (VNA) & PACS Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Vendor Neutral Archive (VNA) & PACS Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Vendor Neutral Archive (VNA) & PACS Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Vendor Neutral Archive (VNA) & PACS Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. CT Image Figure 13. Global CT Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. MRl Image Figure 15. Global MRl Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. X-rays Image Figure 17. Global X-rays Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Ultrasound Image Figure 19. Global Ultrasound Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Mammo Image Figure 21. Global Mammo Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. PET Image Figure 23. Global PET Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. Global Vendor Neutral Archive (VNA) & PACS Market Size Overview by Type (2021-2032) & (US$ Million) Figure 25. Global Vendor Neutral Archive (VNA) & PACS Market Share by Type 2025 VS 2032 Figure 26. North America Vendor Neutral Archive (VNA) & PACS Market Size Share by Type (2021-2032) Figure 27. Europe Vendor Neutral Archive (VNA) & PACS Market Size Share by Type (2021-2032) Figure 28. Asia-Pacific Vendor Neutral Archive (VNA) & PACS Market Size Share by Type (2021-2032) Figure 29. Latin America Vendor Neutral Archive (VNA) & PACS Market Size Share by Type (2021-2032) Figure 30. Middle East and Africa Vendor Neutral Archive (VNA) & PACS Market Size Share by Type (2021-2032) Figure 31. Hospital Image Figure 32. Global Hospital Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Surgery Center Image Figure 34. Global Surgery Center Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Other Image Figure 36. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Global Vendor Neutral Archive (VNA) & PACS Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Vendor Neutral Archive (VNA) & PACS Market Share by Application 2025 VS 2032 Figure 39. North America Vendor Neutral Archive (VNA) & PACS Market Size Share by Application (2021-2032) Figure 40. Europe Vendor Neutral Archive (VNA) & PACS Market Size Share by Application (2021-2032) Figure 41. Asia-Pacific Vendor Neutral Archive (VNA) & PACS Market Size Share by Application (2021-2032) Figure 42. Latin America Vendor Neutral Archive (VNA) & PACS Market Size Share by Application (2021-2032) Figure 43. Middle East and Africa Vendor Neutral Archive (VNA) & PACS Market Size Share by Application (2021-2032) Figure 44. Global Top 5 and 10 Vendor Neutral Archive (VNA) & PACS Players Market Share by Revenue in 2025 Figure 45. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 46. North America Vendor Neutral Archive (VNA) & PACS Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. North America Vendor Neutral Archive (VNA) & PACS Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. North America Vendor Neutral Archive (VNA) & PACS Market Share by Country (2021-2032) Figure 49. Europe Vendor Neutral Archive (VNA) & PACS Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Vendor Neutral Archive (VNA) & PACS Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Vendor Neutral Archive (VNA) & PACS Market Share by Country (2021-2032) Figure 52. Asia-Pacific Vendor Neutral Archive (VNA) & PACS Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Asia-Pacific Vendor Neutral Archive (VNA) & PACS Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Asia-Pacific Vendor Neutral Archive (VNA) & PACS Market Share by Country (2021-2032) Figure 55. Latin America Vendor Neutral Archive (VNA) & PACS Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Vendor Neutral Archive (VNA) & PACS Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Vendor Neutral Archive (VNA) & PACS Market Share by Country (2021-2032) Figure 58. Middle East & Africa Vendor Neutral Archive (VNA) & PACS Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Middle East & Africa Vendor Neutral Archive (VNA) & PACS Market Share by Country: 2021 VS 2025 VS 2032 Figure 60. Middle East & Africa Vendor Neutral Archive (VNA) & PACS Market Share by Country (2021-2032) Figure 61. Years Considered Figure 62. Research Process Figure 63. Key Executives Interviewed

Scope & coverage.

Types
  • CT
  • MRl
  • X-rays
  • Ultrasound
  • Mammo
  • PET
Applications
  • Hospital
  • Surgery Center
  • Other
Companies covered
  • GE Healthcare Technologies Inc.
  • Siemens Healthcare Limited
  • Canon Medical Systems Corporation
  • FUJIFILM Holdings Corporation
  • Agfa-Gevaert Group
  • Sectra AB
  • Hyland Software, Inc.
  • Intelerad Medical Systems Inc
  • Merative
  • Novarad Corporation
  • Esaote SPA
  • Dedalus s.p.A.
  • BridgeHead Software Ltd.
  • PaxeraHealth
  • Medicasoft
  • Visus Health IT GmbH
  • POSTDICOM

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Vendor Neutral Archive (VNA) & PACS Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Vendor Neutral Archive (VNA) & PACS Market Size by Region (2021-2032)
  5. 1.4.1 Global Vendor Neutral Archive (VNA) & PACS Market Size by Region (2021-2026)
  6. 1.4.2 Global Vendor Neutral Archive (VNA) & PACS Market Size by Region (2027-2032)
  7. 1.5 Key Regions Vendor Neutral Archive (VNA) & PACS Market Size (2021-2032)
  8. 1.5.1 North America Vendor Neutral Archive (VNA) & PACS Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Vendor Neutral Archive (VNA) & PACS Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Vendor Neutral Archive (VNA) & PACS Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Vendor Neutral Archive (VNA) & PACS Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Vendor Neutral Archive (VNA) & PACS Market Size Growth Rate (2021-2032)
2 Vendor Neutral Archive (VNA) & PACS Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 CT
  3. 2.1.2 MRl
  4. 2.1.3 X-rays
  5. 2.1.4 Ultrasound
  6. 2.1.5 Mammo
  7. 2.1.6 PET
  8. 2.2 Global Vendor Neutral Archive (VNA) & PACS Market Size by Type
  9. 2.2.1 Global Vendor Neutral Archive (VNA) & PACS Market Size Overview by Type (2021-2032)
  10. 2.2.2 Global Vendor Neutral Archive (VNA) & PACS Historic Market Size Review by Type (2021-2026)
  11. 2.2.3 Global Vendor Neutral Archive (VNA) & PACS Market Size Forecasted by Type (2027-2032)
  12. 2.3 Global Vendor Neutral Archive (VNA) & PACS Market Size by Regions
  13. 2.3.1 North America Vendor Neutral Archive (VNA) & PACS Market Size Breakdown by Type (2021-2026)
  14. 2.3.2 Europe Vendor Neutral Archive (VNA) & PACS Market Size Breakdown by Type (2021-2026)
  15. 2.3.3 Asia-Pacific Vendor Neutral Archive (VNA) & PACS Market Size Breakdown by Type (2021-2026)
  16. 2.3.4 South America Vendor Neutral Archive (VNA) & PACS Market Size Breakdown by Type (2021-2026)
  17. 2.3.5 Middle East and Africa Vendor Neutral Archive (VNA) & PACS Market Size Breakdown by Type (2021-2026)
3 Vendor Neutral Archive (VNA) & PACS Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital
  3. 3.1.2 Surgery Center
  4. 3.1.3 Other
  5. 3.2 Global Vendor Neutral Archive (VNA) & PACS Market Size by Application
  6. 3.2.1 Global Vendor Neutral Archive (VNA) & PACS Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Vendor Neutral Archive (VNA) & PACS Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Vendor Neutral Archive (VNA) & PACS Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Vendor Neutral Archive (VNA) & PACS Market Size by Regions
  10. 3.3.1 North America Vendor Neutral Archive (VNA) & PACS Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Vendor Neutral Archive (VNA) & PACS Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Vendor Neutral Archive (VNA) & PACS Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Vendor Neutral Archive (VNA) & PACS Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Vendor Neutral Archive (VNA) & PACS Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Vendor Neutral Archive (VNA) & PACS Industry Trends
  2. 4.2 Vendor Neutral Archive (VNA) & PACS Industry Drivers
  3. 4.3 Vendor Neutral Archive (VNA) & PACS Industry Opportunities and Challenges
  4. 4.4 Vendor Neutral Archive (VNA) & PACS Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Vendor Neutral Archive (VNA) & PACS Revenue (2021-2026)
  2. 5.2 Global Vendor Neutral Archive (VNA) & PACS Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Vendor Neutral Archive (VNA) & PACS Key Company Headquarters & Area Served
  4. 5.4 Global Vendor Neutral Archive (VNA) & PACS Company, Product Type & Application
  5. 5.5 Global Vendor Neutral Archive (VNA) & PACS Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Vendor Neutral Archive (VNA) & PACS Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Vendor Neutral Archive (VNA) & PACS Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Vendor Neutral Archive (VNA) & PACS Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 GE Healthcare Technologies Inc.
  2. 6.1.1 GE Healthcare Technologies Inc. Company Information
  3. 6.1.2 GE Healthcare Technologies Inc. Business Overview
  4. 6.1.3 GE Healthcare Technologies Inc. Vendor Neutral Archive (VNA) & PACS Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 GE Healthcare Technologies Inc. Vendor Neutral Archive (VNA) & PACS Product Portfolio
  6. 6.1.5 GE Healthcare Technologies Inc. Recent Developments
  7. 6.2 Siemens Healthcare Limited
  8. 6.2.1 Siemens Healthcare Limited Company Information
  9. 6.2.2 Siemens Healthcare Limited Business Overview
  10. 6.2.3 Siemens Healthcare Limited Vendor Neutral Archive (VNA) & PACS Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Siemens Healthcare Limited Vendor Neutral Archive (VNA) & PACS Product Portfolio
  12. 6.2.5 Siemens Healthcare Limited Recent Developments
  13. 6.3 Canon Medical Systems Corporation
  14. 6.3.1 Canon Medical Systems Corporation Company Information
  15. 6.3.2 Canon Medical Systems Corporation Business Overview
  16. 6.3.3 Canon Medical Systems Corporation Vendor Neutral Archive (VNA) & PACS Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Canon Medical Systems Corporation Vendor Neutral Archive (VNA) & PACS Product Portfolio
  18. 6.3.5 Canon Medical Systems Corporation Recent Developments
  19. 6.4 FUJIFILM Holdings Corporation
  20. 6.4.1 FUJIFILM Holdings Corporation Company Information
  21. 6.4.2 FUJIFILM Holdings Corporation Business Overview
  22. 6.4.3 FUJIFILM Holdings Corporation Vendor Neutral Archive (VNA) & PACS Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 FUJIFILM Holdings Corporation Vendor Neutral Archive (VNA) & PACS Product Portfolio
  24. 6.4.5 FUJIFILM Holdings Corporation Recent Developments
  25. 6.5 Agfa-Gevaert Group
  26. 6.5.1 Agfa-Gevaert Group Company Information
  27. 6.5.2 Agfa-Gevaert Group Business Overview
  28. 6.5.3 Agfa-Gevaert Group Vendor Neutral Archive (VNA) & PACS Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Agfa-Gevaert Group Vendor Neutral Archive (VNA) & PACS Product Portfolio
  30. 6.5.5 Agfa-Gevaert Group Recent Developments
  31. 6.6 Sectra AB
  32. 6.6.1 Sectra AB Company Information
  33. 6.6.2 Sectra AB Business Overview
  34. 6.6.3 Sectra AB Vendor Neutral Archive (VNA) & PACS Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Sectra AB Vendor Neutral Archive (VNA) & PACS Product Portfolio
  36. 6.6.5 Sectra AB Recent Developments
  37. 6.7 Hyland Software, Inc.
  38. 6.7.1 Hyland Software, Inc. Company Information
  39. 6.7.2 Hyland Software, Inc. Business Overview
  40. 6.7.3 Hyland Software, Inc. Vendor Neutral Archive (VNA) & PACS Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Hyland Software, Inc. Vendor Neutral Archive (VNA) & PACS Product Portfolio
  42. 6.7.5 Hyland Software, Inc. Recent Developments
  43. 6.8 Intelerad Medical Systems Inc
  44. 6.8.1 Intelerad Medical Systems Inc Company Information
  45. 6.8.2 Intelerad Medical Systems Inc Business Overview
  46. 6.8.3 Intelerad Medical Systems Inc Vendor Neutral Archive (VNA) & PACS Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Intelerad Medical Systems Inc Vendor Neutral Archive (VNA) & PACS Product Portfolio
  48. 6.8.5 Intelerad Medical Systems Inc Recent Developments
  49. 6.9 Merative
  50. 6.9.1 Merative Company Information
  51. 6.9.2 Merative Business Overview
  52. 6.9.3 Merative Vendor Neutral Archive (VNA) & PACS Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Merative Vendor Neutral Archive (VNA) & PACS Product Portfolio
  54. 6.9.5 Merative Recent Developments
  55. 6.10 Novarad Corporation
  56. 6.10.1 Novarad Corporation Company Information
  57. 6.10.2 Novarad Corporation Business Overview
  58. 6.10.3 Novarad Corporation Vendor Neutral Archive (VNA) & PACS Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Novarad Corporation Vendor Neutral Archive (VNA) & PACS Product Portfolio
  60. 6.10.5 Novarad Corporation Recent Developments
  61. 6.11 Esaote SPA
  62. 6.11.1 Esaote SPA Company Information
  63. 6.11.2 Esaote SPA Business Overview
  64. 6.11.3 Esaote SPA Vendor Neutral Archive (VNA) & PACS Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Esaote SPA Vendor Neutral Archive (VNA) & PACS Product Portfolio
  66. 6.11.5 Esaote SPA Recent Developments
  67. 6.12 Dedalus s.p.A.
  68. 6.12.1 Dedalus s.p.A. Company Information
  69. 6.12.2 Dedalus s.p.A. Business Overview
  70. 6.12.3 Dedalus s.p.A. Vendor Neutral Archive (VNA) & PACS Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Dedalus s.p.A. Vendor Neutral Archive (VNA) & PACS Product Portfolio
  72. 6.12.5 Dedalus s.p.A. Recent Developments
  73. 6.13 BridgeHead Software Ltd.
  74. 6.13.1 BridgeHead Software Ltd. Company Information
  75. 6.13.2 BridgeHead Software Ltd. Business Overview
  76. 6.13.3 BridgeHead Software Ltd. Vendor Neutral Archive (VNA) & PACS Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 BridgeHead Software Ltd. Vendor Neutral Archive (VNA) & PACS Product Portfolio
  78. 6.13.5 BridgeHead Software Ltd. Recent Developments
  79. 6.14 PaxeraHealth
  80. 6.14.1 PaxeraHealth Company Information
  81. 6.14.2 PaxeraHealth Business Overview
  82. 6.14.3 PaxeraHealth Vendor Neutral Archive (VNA) & PACS Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 PaxeraHealth Vendor Neutral Archive (VNA) & PACS Product Portfolio
  84. 6.14.5 PaxeraHealth Recent Developments
  85. 6.15 Medicasoft
  86. 6.15.1 Medicasoft Company Information
  87. 6.15.2 Medicasoft Business Overview
  88. 6.15.3 Medicasoft Vendor Neutral Archive (VNA) & PACS Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Medicasoft Vendor Neutral Archive (VNA) & PACS Product Portfolio
  90. 6.15.5 Medicasoft Recent Developments
  91. 6.16 Visus Health IT GmbH
  92. 6.16.1 Visus Health IT GmbH Company Information
  93. 6.16.2 Visus Health IT GmbH Business Overview
  94. 6.16.3 Visus Health IT GmbH Vendor Neutral Archive (VNA) & PACS Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Visus Health IT GmbH Vendor Neutral Archive (VNA) & PACS Product Portfolio
  96. 6.16.5 Visus Health IT GmbH Recent Developments
  97. 6.17 POSTDICOM
  98. 6.17.1 POSTDICOM Company Information
  99. 6.17.2 POSTDICOM Business Overview
  100. 6.17.3 POSTDICOM Vendor Neutral Archive (VNA) & PACS Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 POSTDICOM Vendor Neutral Archive (VNA) & PACS Product Portfolio
  102. 6.17.5 POSTDICOM Recent Developments
7 North America
  1. 7.1 North America Vendor Neutral Archive (VNA) & PACS Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Vendor Neutral Archive (VNA) & PACS Market Size by Country (2021-2026)
  3. 7.3 North America Vendor Neutral Archive (VNA) & PACS Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Vendor Neutral Archive (VNA) & PACS Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Vendor Neutral Archive (VNA) & PACS Market Size by Country (2021-2026)
  3. 8.3 Europe Vendor Neutral Archive (VNA) & PACS Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Vendor Neutral Archive (VNA) & PACS Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Vendor Neutral Archive (VNA) & PACS Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Vendor Neutral Archive (VNA) & PACS Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Vendor Neutral Archive (VNA) & PACS Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Vendor Neutral Archive (VNA) & PACS Market Size by Country (2021-2026)
  3. 10.3 South America Vendor Neutral Archive (VNA) & PACS Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Vendor Neutral Archive (VNA) & PACS Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Vendor Neutral Archive (VNA) & PACS Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Vendor Neutral Archive (VNA) & PACS Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research